Quantitative Structure–Activity Relationships for Human Galectin-3 Inhibitors: Insights from Quantum Chemical Interaction Energy Terms
Abstract
High Resolution Image Download MS PowerPoint Slide Human galectin-3 ( h Gal-3) is a target protein implicated in various diseases, including fibrosis, and several inhibitors have been identified. In this study, we investigated the quantitative structure–activity relationships (QSAR) that influence h Gal-3 binding affinity of 21 inhibitors using four quantum chemical interaction energy terms: electrostatic (ES), charge transfer (CT+mix), exchange (EX), and dispersion interactions (DI). These terms were derived from high-precision fragment molecular orbital (FMO) calculations. Our analysis revealed that the binding affinity could be explained primarily by the CT+mix and DI terms. We further decomposed these terms to analyze the contributions of specific h Gal-3 residues and evaluated the correlations between residue contributions and binding affinity. For CT+mix, key interactions with R144, N160, E184, and R186 were identified, while for DI, interactions with R144 and R186 were the most significant. In the case of CT+mix, we found that charge transfer from E184 to the inhibitor stabilized the CT+mix interaction energy, contributing to the binding affinity. DI analysis revealed that parallel stacking between the aromatic ring of the inhibitor and the guanidine moieties of R144 and R186, as well as CH–π interactions with R186, stabilized the DI-induced interaction energy. Based on these findings, we propose a design guideline for high affinity h Gal-3 inhibitors: lowering the…
Read the paper
Related studies
- Chaos and quantum thermalization
- The Dalton quantum chemistry program system
- Cord Blood Leptin and Adiponectin as Predictors of Adiposity in Children at 3 Years of Age: A Prospective Cohort Study
- Quantitative metabolomics by H-NMR and LC-MS/MS confirms altered metabolic pathways in diabetes
- Stable adiabatic quantum batteries
- A novel self-lipid antigen targets human T cells against CD1c(+) leukemias
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.